Clinical trial
Pilot Study to Assess Performance and Safety of SULFEX 13081.22 Nasal Spray in Patients With Dry or Irritated Nose
NCT05499078 is registered in ClinicalTrials.gov with Church & Dwight Company, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Study to Assess Performance and Safety of SULFEX 13081.22 Nasal Spray in Patients With Dry or Irritated Nose
- Lead sponsor
- Church & Dwight Company, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 2, 2022
- Completion date
- December 31, 2023
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
dry nose, nose irritation